From what I heard, they are now focusing on breast cancer as top priority after years of work on ovarian. Also seem to be saying the primary benefit will be to reduce the number of biopsies needed; none of that old 1000's of times better than a mammogram crap spewed by Manny and Marv.
Biggest financial info: $8+ million in cash, burning $1.3 million/quarter, but this does not include all the expense for outsourcing. They are outsourcing nano particle manufacturing, the design of the human product and the building of the human product. Sounds like a lot more cash will be needed to reach their goal of human trials. jmho, curious to see how others paint it.
News 
Market Data 
Discover 
